Quantcast
Last updated on April 16, 2014 at 7:25 EDT

Latest Aortic valve stenosis Stories

2011-11-11 01:50:34

2-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy A two-year study of patients in the landmark PARTNER trial, which compared transcatheter aortic valve replacement (TAVR) in patients who have severe aortic stenosis and are not candidates for open heart surgery, confirm the one-year findings and support the role of TAVR as the standard of care. Trial results were presented today at the 23rd annual Transcatheter Cardiovascular...

2011-10-25 13:06:37

Open heart surgery may no longer be the only option for third most common type of heart disease A type of medication known as angiotensin-receptor blockers could reduce risk of mortality in people with a heart disease called calcific aortic stenosis (AS) by 30 per cent over an eight-year period, Heart and Stroke Foundation researcher Dr. Philippe Pibarot told delegates at the Canadian Cardiovascular Congress. The condition is currently managed with open heart surgery. "Our discovery...

2011-10-03 15:21:42

University Hospitals Case Medical Center physician-scientists participate in new multidisciplinary program and clinical trial Among individuals 65 years and older, as many as 30 percent have aortic valve sclerosis or stenosis and as a result of their deteriorating health, they cannot enjoy a normal lifestyle. "The aortic valve is a gatekeeper," says Marco Costa, MD, of University Hospitals (UH) Case Medical in Cleveland. "If it isn't functioning properly, there is less blood flow to the...

2011-09-30 13:05:00

CLEVELAND, Sep. 30, 2011 /PRNewswire/ -- Among individuals 65 years and older, as many as 30 percent have aortic valve sclerosis or stenosis and as a result of their deteriorating health, cannot enjoy a normal lifestyle. "The aortic valve is a gatekeeper," says Marco Costa, MD, of University Hospitals (UH) Case Medical in Cleveland. "If it isn't functioning properly, there is less blood flow to the body and patients may experience fatigue, fainting, stroke, poor kidney function and heart...

2011-09-13 23:10:03

While the incidence of the life-threatening condition of aortic dissection is significantly higher than in the general population, it remains low among patients with the congenital heart defect, bicuspid aortic valve; however, the incidence of aortic aneurysms is significantly high, according to a study in the September 14 issue of JAMA. Bicuspid aortic valve (BAV; defect of the aortic valve that results in the formation of two flaps that open and close, instead of the normal three) is the...

2011-08-30 11:29:58

(Less that 20 percent) logistic Euroscore: results of a prospective single center registry Results from a study presented today at the ESC Congress 2011, show that TAVI implantation in low risk patients, met with 100% procedural success (versus 95.3% in the high Euroscore group (p=0.1). "The most interesting point to observe is the absence of death at one month in the low Euroscore group, versus a mortality rate of 11.1% in the high Euroscore group (>20%), (p < 0.04) and this...

2011-08-29 14:16:30

(TAVI) for severe aortic stenosis Severe aortic stenosis (AS) is increasing in frequency as the population ages. For a subset of patients in whom surgical conventional aortic valve replacement is excluded due to severe co-morbidities, an alternative to surgical aortic valve replacement — transcatheter aortic valve replacement (TAVI)- has emerged with a first-in-man case performed in France in 2002 by Pr. Alain Cribier. Since 2002, TAVI has undergone many modifications from first...

2011-08-16 12:21:00

MOUNTAIN VIEW, Calif., Aug. 16, 2011 /PRNewswire/ -- Cardiologists at El Camino Hospital's Heart and Vascular Institute are taking advantage of advancements in medical technology to offer patients more options for treating heart disease, and to more precisely determine whether to intervene. In a recent overview and progress report presented to the hospital's Board of Directors, the Institute's Medical Director Dominick Curatola, MD, said the Institute is using such advanced technology as...

2011-06-10 06:39:37

(Ivanhoe Newswire) -- Aortic stenosis is associated with a high rate of death if left untreated. Some patients though are put at too much risk for traditional treatment, so scientists have developed a new and less invasive method for those patients. Transcatheter aortic-valve replacement treats aortic stenosis by replacing the original valve with a bioprosthetic valve. In this study, 699 patients with severe aortic stenosis were enrolled in the trial. 23-percent were considered high risk and...

2011-06-07 00:00:31

Study to enroll patients with severe aortic stenosis for nonsurgical aortic valve replacement. Milwaukee (PRWEB) June 06, 2011 Aurora St. Luke's Medical Center, a leader in heart care, will participate in a national clinical trial that offers patients a less invasive treatment for aortic valve disease. Aurora St. Luke's is among 40 sites in the nation and the only one in Wisconsin selected for the Medtronic CoreValve trial. The trial offers high-risk patients, who might not survive the...